Stratos Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.74M | Buy |
9,217
+461
| +5% | +$187K | 0.17% | 100 |
|
|
2025
Q1 | $4.36M | Buy |
8,756
+1,326
| +18% | +$660K | 0.23% | 85 |
|
|
2024
Q4 | $3.87M | Sell |
7,430
-306
| -4% | -$159K | 0.23% | 81 |
|
|
2024
Q3 | $4.79M | Buy |
7,736
+412
| +6% | +$255K | 0.33% | 70 |
|
|
2024
Q2 | $4.05M | Buy |
7,324
+471
| +7% | +$260K | 0.34% | 75 |
|
|
2024
Q1 | $3.98M | Buy |
6,853
+251
| +4% | +$146K | 0.39% | 68 |
|
|
2023
Q4 | $3.5M | Buy |
6,602
+604
| +10% | +$321K | 0.41% | 62 |
|
|
2023
Q3 | $3.04M | Buy |
5,998
+294
| +5% | +$149K | 0.45% | 60 |
|
|
2023
Q2 | $2.98M | Buy |
5,704
+5
| +0.1% | +$2.61K | 0.46% | 56 |
|
|
2023
Q1 | $3.28M | Sell |
5,699
-70
| -1% | -$40.3K | 0.55% | 54 |
|
|
2022
Q4 | $3.18M | Buy |
5,769
+157
| +3% | +$86.5K | 0.57% | 52 |
|
|
2022
Q3 | $2.85M | Sell |
5,612
-547
| -9% | -$277K | 0.58% | 49 |
|
|
2022
Q2 | $3.35M | Buy |
6,159
+50
| +0.8% | +$27.2K | 0.63% | 47 |
|
|
2022
Q1 | $3.61M | Sell |
6,109
-87
| -1% | -$51.4K | 0.6% | 51 |
|
|
2021
Q4 | $4.13M | Sell |
6,196
-283
| -4% | -$189K | 0.65% | 48 |
|
|
2021
Q3 | $3.7M | Buy |
6,479
+1,913
| +42% | +$1.09M | 0.64% | 48 |
|
|
2021
Q2 | $2.3M | Buy |
4,566
+294
| +7% | +$148K | 0.63% | 52 |
|
|
2021
Q1 | $1.95M | Sell |
4,272
-277
| -6% | -$126K | 0.62% | 52 |
|
|
2020
Q4 | $2.12M | Buy |
4,549
+316
| +7% | +$147K | 0.67% | 51 |
|
|
2020
Q3 | $1.87M | Sell |
4,233
-1,701
| -29% | -$751K | 0.68% | 46 |
|
|
2020
Q2 | $2.15M | Buy |
5,934
+268
| +5% | +$97.1K | 0.91% | 35 |
|
|
2020
Q1 | $1.61M | Buy |
5,666
+4,199
| +286% | +$1.19M | 0.86% | 36 |
|
|
2019
Q4 | $476K | Buy |
+1,467
| New | +$476K | 0.22% | 78 |
|